COMPARISON OF DIFFERENT REMISSION INDICES IN PATIENTS WITH PSORIATIC ARTHRITIS: A POST HOC ANALYSIS OF DATA FROM PHASE 3 TOFACITINIB STUDIES

被引：0
|
作者：
Schneeberger, Emilce E. [1 ]
Citera, Gustavo [1 ]
Nash, Peter [2 ]
Smolen, Josef S. [3 ]
Mease, Philip [4 ,5 ]
Soriano, Enrique R. [6 ]
Helling, Claudia [7 ]
Szumski, Annette [8 ]
Mundayat, Rajiv [9 ]
Graham, Daniela [10 ]
Ponce de Leon, Dario [11 ]
机构：
[1] Inst Rehabil Psicofis, Buenos Aires, DF, Argentina
[2] Griffith Univ, Dept Med, Brisbane, Qld, Australia
[3] Med Univ Vienna, Vienna, Austria
[4] Swedish Med Ctr, Seattle, WA USA
[5] Univ Washington, Seattle, WA 98195 USA
[6] Hosp Italiano Buenos Aires, Buenos Aires, DF, Argentina
[7] Pfizer Inc, Buenos Aires, DF, Argentina
[8] Pfizer Inc, Collegeville, PA USA
[9] Pfizer Inc, New York, NY USA
[10] Pfizer Inc, Groton, CT 06340 USA
[11] Pfizer Inc, Lima, Peru
来源：
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY | 2020年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
272
引用
收藏
页码：6 / 7
页数：2
相关论文
共 50 条
  • [1] Comparison of Different Remission Indices in Patients with Psoriatic Arthritis: A Post Hoc Analysis of Data from Phase 3 Tofacitinib Studies
    Citera, Gustavo
    Schneeberger, Emilce
    Nash, Peter
    Smolen, Josef
    Mease, Philip
    Soriano, Enrique
    Matulic, Vesna
    Helling, Claudia
    Szumski, Annette
    Mundayat, Rajiv
    Graham, Daniela
    Ponce de Leon, Dario
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [2] COMPARISON OF DIFFERENT REMISSION INDICES IN PATIENTS WITH PSORIATIC ARTHRITIS: A POST HOC ANALYSIS OF DATA FROM PHASE 3 TOFACITINIB STUDIES
    Schneeberger, E.
    Citera, G.
    Nash, P.
    Smolen, J. S.
    Mease, P. J.
    Soriano, E.
    Helling, C.
    Szumski, A. E.
    Mundayat, R.
    Graham, D.
    Ponce de Leon, D.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1716 - 1717
  • [3] Tofacitinib in Patients With Psoriatic Arthritis and Metabolic Syndrome: A Post hoc Analysis of Phase 3 Studies
    Ritchlin, Christopher T.
    Giles, Jon T.
    Ogdie, Alexis
    Gomez-Reino, Juan J.
    Helliwell, Philip
    Young, Pamela
    Wang, Cunshan
    Wu, Joseph
    Romero, Ana Belen
    Woolcott, John
    Stockert, Lori
    ACR OPEN RHEUMATOLOGY, 2020, 2 (10) : 543 - 554
  • [4] TOFACITINIB IN PATIENTS WITH PSORIATIC ARTHRITIS AND METABOLIC SYNDROME: A POST-HOC ANALYSIS OF PHASE 3 STUDIES
    Ritchlin, C.
    Giles, J.
    Ogdie, A.
    Gomez-Reino, J.
    Stockert, L.
    Young, P.
    Wang, C.
    Romero, A. B.
    Kudlacz, E.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1023 - 1023
  • [5] Comparison of disease activity index for psoriatic arthritis (DAPSA) and minimal disease activity (MDA) targets for patients with psoriatic arthritis: A post hoc analysis of data from phase 3 tofacitinib studies
    Schneeberger, Emilce E.
    Citera, Gustavo
    Nash, Peter
    Smolen, Josef S.
    Mease, Philip J.
    Soriano, Enrique R.
    Helling, Claudia
    Szumski, Annette E.
    Mundayat, Rajiv
    de Leon, Dario Ponce
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2023, 58
  • [6] Efficacy of Tofacitinib By Background Methotrexate Dose in Patients with Psoriatic Arthritis: A Post Hoc Analysis of Pooled Data from 2 Phase 3 Trials
    Kivitz, Alan J.
    FitzGerald, Oliver
    Nash, Peter
    Pang, Shirley
    Azevedo, Valderilio F.
    Kudlacz, Elizabeth
    Wang, Cunshan
    Graham, Daniela
    Takiya, Liza
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [7] EFFICACY OF TOFACITINIB BY BACKGROUND METHOTREXATE DOSE IN PATIENTS WITH PSORIATIC ARTHRITIS: A POST-HOC ANALYSIS OF POOLED DATA FROM 2 PHASE 3 TRIALS
    Kivitz, A. J.
    FitzGerald, O.
    Nash, P.
    Pang, S.
    Azevedo, V. F.
    Kudlacz, E.
    Wang, C.
    Graham, D.
    Takiya, L.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1575 - 1575
  • [8] Joint-specific Responses to Tofacitinib and Adalimumab in Patients with Psoriatic Arthritis: Post Hoc Analysis of a Phase 3 Study
    Ciurea, Adrian
    Killeen, Tim
    Micheroli, Raphael
    Gassman, Norina N.
    Jo, Hyejin
    Kwok, Kenneth
    Kudlacz, Elizabeth
    Distler, Oliver
    Ospelt, Caroline
    Frank-Bertoncelj, Mojca
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 2811 - 2814
  • [9] TOFACITINIB IN PATIENTS WITH PSORIATIC ARTHRITIS: ANALYSIS OF DERMATOLOGIC ENDPOINTS FROM 2 PHASE 3 STUDIES
    Merola, Joseph F.
    Papp, Kim
    Nash, Peter
    Gratacos-Masmitja, Jordi
    Boehncke, Wolf-Henning
    Thaci, Diamant
    Graham, Daniela
    Hsu, Ming-Ann
    Wang, Cunshan
    Wu, Joseph
    Young, Pamela
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 918 - 918
  • [10] Characterization of Remission in Patients with Psoriatic Arthritis Treated with Upadacitinib: Post-hoc Analysis from Two Phase 3 Trials
    Gladman, Dafna
    Kavanaugh, Arthur
    FitzGerald, Oliver
    Soriano, Enrique
    Nash, Peter
    Feng, Dai
    Lertratanakul, Apinya
    Douglas, Kevin
    Lippe, Ralph
    Gossec, Laure
    Mease, Philip
    JOURNAL OF RHEUMATOLOGY, 2021, 48 (07) : 1115 - 1115
12345